Oz Shapira - Allmed Solutions Chief Officer
Insider
Oz Shapira is Chief Officer of Allmed Solutions
| Phone | 972 4 627 7166 |
| Web | https://www.allium-medical.com |
Allmed Solutions Management Efficiency
The company has return on total asset (ROA) of (0.1121) % which means that it has lost $0.1121 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1555) %, meaning that it generated substantial loss on money invested by shareholders. Allmed Solutions' management efficiency ratios could be used to measure how well Allmed Solutions manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 2.16 M in total debt with debt to equity ratio (D/E) of 0.04, which may suggest the company is not taking enough advantage from borrowing. Allmed Solutions has a current ratio of 6.81, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Allmed Solutions until it has trouble settling it off, either with new capital or with free cash flow. So, Allmed Solutions' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Allmed Solutions sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Allmed to invest in growth at high rates of return. When we think about Allmed Solutions' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Arnon MD | Clal Biotechnology Industries | 54 | |
| Etty Kliger | Clal Biotechnology Industries | N/A | |
| Or Yogev | Augwind Energy Tech | N/A | |
| Vered Kivity | Bonus Biogroup | N/A | |
| CPA Raveh | Augwind Energy Tech | 53 | |
| Liron MBA | BioLine RX | N/A | |
| Holly MBA | BioLine RX | N/A | |
| Avner Stern | Augwind Energy Tech | 41 | |
| John Lacey | BioLine RX | N/A | |
| Yaacov Vinokur | Augwind Energy Tech | 45 | |
| CPA MBA | BioLine RX | 62 | |
| Iris Sadeh | Clal Biotechnology Industries | N/A | |
| Oded Lilian | Augwind Energy Tech | 50 | |
| Pr MD | Clal Biotechnology Industries | 77 | |
| Yoni CPA | Bonus Biogroup | 48 | |
| Liat Nissan | Clal Biotechnology Industries | N/A | |
| Shiran Manor | Clal Biotechnology Industries | N/A | |
| Raziel Fried | BioLine RX | N/A | |
| Advocate Kotler | BioLine RX | 71 | |
| Jael MSc | BioLine RX | N/A | |
| LLB BSc | BioLine RX | N/A | |
Management Performance
| Return On Equity | -0.16 | |||
| Return On Asset | -0.11 |
Allmed Solutions Leadership Team
Elected by the shareholders, the Allmed Solutions' board of directors comprises two types of representatives: Allmed Solutions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Allmed. The board's role is to monitor Allmed Solutions' management team and ensure that shareholders' interests are well served. Allmed Solutions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Allmed Solutions' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shay Arotchas, Vice President - Operations | ||
| Etan Hillman, External Director | ||
| Erez Keinan, Vice President - Finance | ||
| Ariel Rubashkin, Vice President - Finance | ||
| Abraham Nahmias, Chairman of the Board | ||
| Jacob Dagan, Independent Director | ||
| Assaf Alperovitz, Chief Executive Officer | ||
| Daniel Spira, Internal Auditor | ||
| Oz Shapira, Chief Officer | ||
| Rinat Gazit, External Director | ||
| Shai Tag, Finance Director | ||
| Ziv Kalfon, Vice President-Engineering & Technology | ||
| David Milch, Director | ||
| Ehud Geller, Director | ||
| Eitan Hod, VP RA | ||
| David MD, Founder Chairman |
Allmed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Allmed Solutions a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.16 | |||
| Return On Asset | -0.11 | |||
| Operating Margin | (36.89) % | |||
| Current Valuation | 13.15 M | |||
| Shares Outstanding | 80.82 M | |||
| Shares Owned By Insiders | 44.71 % | |||
| Price To Earning | 147.17 X | |||
| Price To Book | 0.51 X | |||
| Price To Sales | 85.68 X | |||
| Revenue | 5.54 M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allmed Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as various price indices. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Allmed Stock analysis
When running Allmed Solutions' price analysis, check to measure Allmed Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allmed Solutions is operating at the current time. Most of Allmed Solutions' value examination focuses on studying past and present price action to predict the probability of Allmed Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allmed Solutions' price. Additionally, you may evaluate how the addition of Allmed Solutions to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |